A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33
Gloria M. Petersen(Mayo Clinic), Hemang Parikh(University of South Florida), Robert R. McWilliams(Mayo Clinic in Arizona), Harvey A. Risch(University of New Haven), Susan E. Hankinson(University of Massachusetts Amherst), J. Michael Gaziano(VA Boston Healthcare System), Steven Gallinger(Ontario Institute for Cancer Research), Barbara V. Howard(MedStar Health), Alan A. Arslan(New York University), Demetrius Albanes(National Cancer Institute), Alison P. Klein(Johns Hopkins University), Rudolf Kaaks(German Cancer Research Center), William R. Bamlet(Mayo Clinic), Edward L. Giovannucci(Massachusetts Department of Public Health), Mariza de Andrade(Mayo Clinic), Laufey T. Ámundadóttir(National Institutes of Health), Mazda Jenab(Centre international de recherche sur le cancer), Charles S. Fuchs(University of Southern California), Paige M. Bracci(University of California, San Francisco), Sara H. Olson(Memorial Sloan Kettering Cancer Center), Eric J. Jacobs(American Cancer Society), Peter Kraft(National Cancer Institute), Sandra Clipp(Johns Hopkins University), Dominique S. Michaud(National Cancer Institute), Marie‐Christine Boutron‐Ruault(Université Paris-Sud), Michelle Cotterchio(University of Toronto), Eric J. Duell(Dartmouth College), Rachael Z. Stolzenberg‐Solomon(National Cancer Institute), Andrea Z. LaCroix(Human Longevity (United States)), Shannon M. Lynch(Fox Chase Cancer Center), David J. Hunter(The University of Sydney), Margaret T. Mandelson(Group Health Cooperative), Kevin B. Jacobs(Emergent BioSolutions (United States)), Julie B. Mendelsohn(National Institutes of Health), Vittorio Krogh(Istituti di Ricovero e Cura a Carattere Scientifico), Amy Hutchinson(National Institutes of Health), Robert C. Kurtz(Memorial Sloan Kettering Cancer Center), Michael Goggins(Johns Hopkins University), Julie E. Buring(Brigham and Women's Hospital), Donghui Li(The University of Texas MD Anderson Cancer Center), Wei Zheng(Vanderbilt University), Göran Hallmans(Umeå University), Christine D. Berg(Prevention Group), Kathy J. Helzlsouer(Mercy Medical Center), Myron D. Gross(University of Minnesota), H. Bas Bueno‐de‐Mesquita(University Medical Center Utrecht), Elizabeth A. Holly(University of California, San Francisco), Charles Kooperberg(Fred Hutch Cancer Center), Manal M. Hassan(The University of Texas MD Anderson Cancer Center), Federico Canzian(German Cancer Research Center)
Cited by 614
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k